|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $1,242 and $1,479 | ||||||||||||||||||||
| Income Taxes Receivable | ||||||||||||||||||||
| Prepaid and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Fixed assets, net | ||||||||||||||||||||
| Acquired intangible assets, net | ||||||||||||||||||||
| Capitalized contract costs | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Operating lease right-of-use-assets (as reported) | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Equity Method Investments | ||||||||||||||||||||
| Investments, Fair Value Disclosure | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Operating lease liabilities - current | ||||||||||||||||||||
| Taxes Payable, Current | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net | ||||||||||||||||||||
| Deferred Revenue, Noncurrent | ||||||||||||||||||||
| Accrual for unrecognized tax benefits | ||||||||||||||||||||
| Deferred Tax Liabilities, Tax Deferred Income | ||||||||||||||||||||
| Operating lease liabilities - non-current (as reported) | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Preferred Stock, Shares Issued | ||||||||||||||||||||
| Series 1 Participating Preferred Stock | ||||||||||||||||||||
| Series 1 Participating Preferred Stock | ||||||||||||||||||||
| Total preferred Stock, Shares Issued | ||||||||||||||||||||
| Stockholders equity | ||||||||||||||||||||
| Convertible preferred stock, $.01 par value, authorized 20,000 shares; no shares issued and outstanding | ||||||||||||||||||||
| Series 1 Participating Preferred Stock | ||||||||||||||||||||
| Series 1 Participating Preferred Stock | ||||||||||||||||||||
| Total convertible preferred stock, $.01 par value, authorized 20,000 shares; no shares issued and outstanding | ||||||||||||||||||||
| Common stock, $.01 par value, authorized 240,000; issued: 56,959 and 55,619 shares, respectively; outstanding: 43,135 and 44,460 shares, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated earnings | ||||||||||||||||||||
| Treasury Stock, Common, Shares | ||||||||||||||||||||
| Treasury stock, 13,824 and 11,159 shares, respectively | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
| Preferred Stock, Par or Stated Value Per Share | ||||||||||||||||||||
| Series 1 Participating Preferred Stock | ||||||||||||||||||||
| Total preferred Stock, Par or Stated Value Per Share | ||||||||||||||||||||
| Common stock, shares outstanding | ||||||||||||||||||||
| Common stock, shares issued | ||||||||||||||||||||
| Common stock, shares authorized | ||||||||||||||||||||
| Preferred Stock, Shares Authorized | ||||||||||||||||||||
| Series 1 Participating Preferred Stock | ||||||||||||||||||||
| Series 1 Participating Preferred Stock | ||||||||||||||||||||
| Total preferred Stock, Shares Authorized | ||||||||||||||||||||
| Preferred Stock, Shares Outstanding | ||||||||||||||||||||
| Series 1 Participating Preferred Stock | ||||||||||||||||||||
| Series 1 Participating Preferred Stock | ||||||||||||||||||||
| Total preferred Stock, Shares Outstanding | ||||||||||||||||||||
Loading...